Every story in this section, newest first — page 48 of 373.
SLB (NYSE:SLB) announced that it has been awarded four integrated well construction contracts by Saudi Aramco to support oil and gas development projects across the Kingdom of Saudi Arabia.
Mobix Labs (NASDAQ:MOBX) announced that it expects fiscal fourth-quarter 2026 revenue to exceed the midpoint of its previous guidance range as demand improves across its wireless systems and connectivity businesses.
Pasqal (NYSE:PSQL) reported first-half 2026 revenue of €4.9 million for the six months ended June 30, 2026, representing a 14% increase compared with the prior-year period.
Acadia Pharmaceuticals (NASDAQ:ACAD) announced Phase 3-enabling topline results from the Phase 2 portion of its ongoing RADIANT clinical trial program evaluating remlifanserin for hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP).
Redwire Corporation (NYSE:RDW) announced that it has been selected by Space Systems Command as one of 15 vendors awarded a multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract for the National Space Test and Training Complex Innovative Technology and Engineering – Space Test and Range (NITE-STAR) Capability Development program.
TurboGen (NASDAQ:TRBG) reported a net loss of $4.2 million for the first half of 2026 as the company continued development and commercialization efforts for its microturbine energy systems.
TD SYNNEX (NYSE:SNX) reported record financial results for its fiscal third quarter ended August 31, 2026, with revenue and profitability exceeding the company’s expectations.
Darden Restaurants (NYSE:DRI) reported first-quarter fiscal 2027 sales of $3.2 billion for the period ended August 30, 2026, representing a 5.1% increase compared with the prior-year quarter.
BlackBerry (NYSE:BB) reported second-quarter fiscal 2027 revenue of $163.3 million for the three months ended August 31, 2026, representing a 26% increase compared with the prior-year period.
Merck (NYSE:MRK) announced topline results from the pivotal Phase 2b/3 BRUNELLO trial evaluating remigromig (MK-3000, formerly EYE103) in adults with diabetic macular edema (DME).
Eli Lilly (NYSE:LLY) received U.S. Food and Drug Administration approval on September 24, 2026, for Onswik, a once-weekly basal insulin treatment for adults with type 2 diabetes.
Biodesix (NASDAQ:BDSX) announced progress on two molecular residual disease (MRD) testing programs designed to detect circulating tumor DNA (ctDNA) in blood samples following cancer treatment.
Vertiv (NYSE:VRT) agreed on September 24, 2026, to acquire King Environmental Services (KES), a Europe-based provider of fluid-management services for data centers and critical infrastructure applications.
Fervo Energy (NYSE:FRVO) announced that its Cape Station geothermal project in Utah achieved First Power on September 24, 2026, marking the start of electricity exports from the facility.
Sequans Communications (NYSE:SQNS) completed the sale of its remaining 314 Bitcoin holdings, ending its Bitcoin treasury strategy and refocusing on its semiconductor business.
MediciNova (NASDAQ:MNOV) announced the completion of the last patient’s final visit in the double-blind portion of its Phase 2b/3 COMBAT-ALS trial evaluating MN-166 (ibudilast) for amyotrophic lateral sclerosis (ALS).
aTyr Pharma (NASDAQ:ATYR) announced FDA alignment on the planned Phase 3 study protocol for efzofitimod in patients with pulmonary sarcoidosis on September 24, 2026.
Kyverna Therapeutics (NASDAQ:KYTX) reported updated clinical data for its investigational CAR-T therapy miv-cel (mivocabtagene autoleucel) in stiff person syndrome (SPS) and generalized myasthenia gravis (gMG).
RTX (NYSE:RTX) and United Airlines marked the delivery of the first Airbus A321XLR aircraft powered by Pratt & Whitney’s GTF Advantage engine on September 24, 2026.
MGM Resorts International (NYSE:MGM) shares fell 8.38% to $34.68 in premarket trading after People withdrew its proposal to acquire the remaining public shares of the casino operator.
Oil prices rose more than 2% on Thursday as uncertainty over US-Iran negotiations and possible diesel export restrictions supported crude prices.
Uxin (NASDAQ:UXIN) reported revenue of RMB1,151.2 million for the quarter ended June 30, 2026, an increase of 74.9% from the same period last year.
Four Corners Property Trust (NYSE:FCPT) acquired an automotive service property leased to a national operator for $3.5 million through a sale-leaseback transaction.
HUTCHMED (NASDAQ:HCM) will present results from two Phase III studies evaluating savolitinib combined with osimertinib in lung cancer patients at ESMO Congress 2026.
